Patients with non-metastatic GIST treated with neoadjuvant TKIs prior to surgery experienced a benefit which led to less ...

The focus of the presentation will be on the subgroup of patients who have received 100mg bezuclastinib for at least 48 weeks to highlight the symptomatic benefits of long-term use.

Despite significant dips in its vaccines sales, the British pharma narrowly beat consensus estimates for Q4 2024 and raised ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

6 The Carney triad, caused by mutation of the SDH gene, is a rare, nonhereditary condition characterized by the presence of 3 different types of tumors: GISTs ... chronic pain, gastrointestinal ...

Blueprint Medicines (NASDAQ:BPMC – Get Free Report) had its price target upped by equities research analysts at JPMorgan ...

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

A novel 3D bioprinted gastric cancer model using patient-derived tissues predicts drug responses, enhancing personalized ...

A collaborative research team from POSTECH has successfully developed a gastric cancer model using 3D bioprinting technology ...

Mara Sherman, PhD, was awarded the Mark Foundation 2025 Emerging Leader Award, which honored five early-career scientists dedicated to revolutionizing cancer research through innovative projects. Dr.